Mosaic merger brings Northern Biologics back to LIF(E)
DUBLIN – Northern Biologics Inc. is merging with Spanish firm Mosaic Biomedicals SL and at the same time has lined up Celgene Corp. with an option to take forward Mosaic's key asset, MSC-1, a first-in-class antibody that targets leukemia inhibitory factor.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST